These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 36113669)

  • 1. COVID-19: Vaccines and therapeutics.
    Ponnampalli S; Venkata Suryanarayana Birudukota N; Kamal A
    Bioorg Med Chem Lett; 2022 Nov; 75():128987. PubMed ID: 36113669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Therapeutics for COVID-19, What We Know about the Molecular Mechanism and Efficacy of Treatments for This Novel Virus.
    Narayanan D; Parimon T
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Pandemic of Coronavirus Disease 2019 (COVID-19).
    Rashid NN
    Curr Mol Med; 2022; 22(9):761-765. PubMed ID: 34789125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutics and Vaccines: Strengthening Our Fight Against the Global Pandemic COVID-19.
    Bhattacharjee A; Saha M; Halder A; Debnath A; Mukherjee O
    Curr Microbiol; 2021 Feb; 78(2):435-448. PubMed ID: 33392670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19).
    Ahn DG; Shin HJ; Kim MH; Lee S; Kim HS; Myoung J; Kim BT; Kim SJ
    J Microbiol Biotechnol; 2020 Mar; 30(3):313-324. PubMed ID: 32238757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics.
    Forchette L; Sebastian W; Liu T
    Curr Med Sci; 2021 Dec; 41(6):1037-1051. PubMed ID: 34241776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct Molecular Mechanisms Characterizing Pathogenesis of SARS-CoV-2.
    Lee SJ; Kim YJ; Ahn DG
    J Microbiol Biotechnol; 2022 Sep; 32(9):1073-1085. PubMed ID: 36039385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
    Gudadappanavar AM; Benni J
    J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for the development and approval of COVID-19 vaccines and therapeutics in the post-pandemic period.
    Ao D; He X; Liu J; Xu L
    Signal Transduct Target Ther; 2023 Dec; 8(1):466. PubMed ID: 38129394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel zoonotic COVID-19 pandemic: An expected global health concern.
    Contini C; Di Nuzzo M; Barp N; Bonazza A; De Giorgio R; Tognon M; Rubino S
    J Infect Dev Ctries; 2020 Mar; 14(3):254-264. PubMed ID: 32235085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
    Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
    Elife; 2022 Feb; 11():. PubMed ID: 35191378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 vaccine research and immunization strategies for improved control of the COVID-19 pandemic.
    Shao Y; Wu Y; Feng Y; Xu W; Xiong F; Zhang X
    Front Med; 2022 Apr; 16(2):185-195. PubMed ID: 35226300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilizing nanozymes for combating COVID-19: advancements in diagnostics, treatments, and preventative measures.
    Wang J; Xie Q; Song H; Chen X; Zhang X; Zhao X; Hao Y; Zhang Y; Li H; Li N; Fan K; Wang X
    J Nanobiotechnology; 2023 Jun; 21(1):200. PubMed ID: 37344839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2: An Update on Genomics, Risk Assessment, Potential Therapeutics and Vaccine Development.
    Mehmood I; Ijaz M; Ahmad S; Ahmed T; Bari A; Abro A; Allemailem KS; Almatroudi A; Tahir Ul Qamar M
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33567746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
    Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
    mBio; 2020 Sep; 11(5):. PubMed ID: 32978313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outbreak of COVID-19: A Detailed Overview and Its Consequences.
    Shivalkar S; Pingali MS; Verma A; Singh A; Singh V; Paital B; Das D; Varadwaj PK; Samanta SK
    Adv Exp Med Biol; 2021; 1353():23-45. PubMed ID: 35137366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.